Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Montelukast (Singulair) and Symbicort (budesonide/formoterol) are both used to manage asthma, but they work in different ways and have distinct uses. Montelukast is a leukotriene receptor antagonist taken orally, which helps reduce inflammation and swelling by blocking leukotrienes. It's also used for treating year-round and seasonal allergies and preventing exercise-induced asthma. Symbicort, on the other hand, is an inhaler that combines a corticosteroid (budesonide) and a long-acting beta-agonist (formoterol) to reduce lung inflammation and relax airway muscles. Symbicort is used for both asthma and chronic obstructive pulmonary disease (COPD). Montelukast is typically taken once daily, while Symbicort is used twice daily. Montelukast is available in generic form and is suitable for children as young as 1 year old, whereas Symbicort is available in two strengths and is safe for children 6 years and older for asthma. Montelukast can cause serious mental health side effects, while Symbicort may lead to oral thrush and bone loss with long-term use.
Montelukast (Singular)
Symbicort (budesonide / formoterol)
Montelukast (Singular)
Symbicort (budesonide / formoterol)
Summary of Singular vs. Symbicort
Summary for Leukotriene receptor antagonist
Prescription only
Montelukast, the generic for Singulair, is used to help control asthma over time and prevent breathing problems during exercise in both adults and children. It's also used to help relieve allergy symptoms. Montelukast (Singular) comes as tablets, chewable tablets, or oral granules and is usually taken by mouth once a day. Common side effects include upper respiratory infection and headache, and it has a boxed warning for serious mood and behavior changes.
Summary for Inhaled corticosteroid / LABA
Prescription only
Symbicort (budesonide / formoterol) is a combination inhaler used to treat asthma and chronic obstructive pulmonary disease (COPD). It contains two medications: budesonide, a steroid, and formoterol, a long-acting beta-agonist (LABA). Both medications work together to reduce inflammation in the lungs and open up your airways. The typical dose is two puffs by mouth twice a day, usually about 12 hours apart. Common side effects include common cold symptoms, headache, and sore throat.
Indications of Singular vs. Symbicort
Indications for
•Long-term treatment of asthma - age 12 months and older